Stratified administration of serotonin 5-HT3 receptor antagonists (setrons) for chemotherapy-induced emesis. Economic implications.

Author: BartelS B, HoldsworthM, SanchezL A

Paper Details 
Original Abstract of the Article :
The serotonin 5-HT3 receptor antagonists or 'setrons' have become the standard of care for the prevention of chemotherapy-induced emesis (CIE) and are first-line therapy for acute CIE in healthcare organisations worldwide. However, their superior efficacy versus standard antiemetics comes at a signi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.2165/00019053-200018060-00002

データ提供:米国国立医学図書館(NLM)

Stratified Administration of Serotonin 5-HT3 Receptor Antagonists: A Cost-Effective Approach for Chemotherapy-Induced Emesis

Chemotherapy-induced emesis (CIE) is a common and often debilitating side effect of cancer treatment. This study explores the cost-effectiveness of stratified administration of serotonin 5-HT3 receptor antagonists, known as 'setrons,' for the prevention and treatment of CIE. The authors argue that tailoring setron dosage to the emetogenic potential of the chemotherapy regimen can provide both clinical and economic benefits.

Optimizing Treatment for Chemotherapy-Induced Emesis

This research is like navigating a desert landscape, where resource management is crucial. The authors advocate for a more personalized approach to managing CIE, tailoring setron dosage to match the severity of the emetogenic challenge. This strategy, likened to a wise traveler using water resources wisely, can improve patient outcomes and reduce healthcare costs.

Navigating Chemotherapy Side Effects Effectively

Chemotherapy, a powerful tool against cancer, can sometimes be accompanied by unwelcome side effects. Understanding the effectiveness and cost-effectiveness of different treatment strategies for CIE can empower patients and healthcare providers to make informed decisions, ensuring a smoother journey through cancer treatment.

Dr.Camel's Conclusion

This research emphasizes the importance of tailored treatment approaches for CIE. It's like a desert traveler choosing the right path based on the terrain and resources available. By optimizing setron dosage based on the emetogenic potential of chemotherapy, healthcare providers can improve patient well-being and achieve cost-effective outcomes.

Date :
  1. Date Completed 2001-03-29
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

11227393

DOI: Digital Object Identifier

10.2165/00019053-200018060-00002

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.